Internal Medicine, Medical Oncology · Henderson, NV
NPI
1609814417
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2350 Corporate Cir Ste 100
Henderson, NV, 89074
Phone (702) 968-7210
Groups this clinician bills Medicare through
Medicare paid, 2024
$391K
21,746 services
Medicare patients, 2024
58
Average age 75
Drug cost, 2024
$7.6M
1,209 prescriptions
Company payments, 2025
$99.99
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Steven W Yates was code 85025 (blood count), 153 times for 34 patients. In total Steven W Yates billed 21,746 services in 64 codes, and Medicare paid $391K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-02-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 85025 Blood Count | Office | 153 | 34 | $7.61 | $1,164 |
| 36415 Venipuncture Blood Collection | Office | 143 | 32 | $8.65 | $1,237 |
| 99214 Office E&M - Established | Office | 76 | 32 | $95.76 | $7,278 |
| 80053 Clinical Chemistry | Office | 26 | 16 | $10.35 | $269 |
| 99213 Office E&M - Established | Office | 20 | 15 | $54.46 | $1,089 |
| 82728 Clinical Chemistry | Office | 13 | 11 | $13.36 | $174 |
| 99215 Office E&M - Established | Office | 11 | 11 | $132.53 | $1,458 |
By year: 2022 $88K for 3,519 services; 2023 $246K for 22,781 services; 2024 $391K for 21,746 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 153 | 34 | $7.61 | $1,164 |
| 36415 Venipuncture Blood Collection | 143 | 32 | $8.65 | $1,237 |
| 80053 Clinical Chemistry | 26 | 16 | $10.35 | $269 |
| 82728 Clinical Chemistry | 13 | 11 | $13.36 | $174 |
Medicare prescription drug claims, 2024
In 2024, the drug Steven W Yates prescribed most often to Medicare patients was Revlimid (Lenalidomide), with 106 prescriptions and refills. In total Steven W Yates wrote 1,209 Medicare prescriptions that cost $7.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Revlimid Lenalidomide | 106 | 106 | 16 | $2.0M |
| Anastrozole Generic | 78 | 183 | 25 | $1,067 |
| Prednisone Generic | 68 | 98 | 26 | $327 |
| Ondansetron Odt Ondansetron | 44 | 44 | 28 | $696 |
| Hydroxyurea Generic | 41 | 86 | 16 | $984 |
| Imbruvica Ibrutinib | 41 | 41 | Under 11 | $537K |
| Mirtazapine Generic | 37 | 45 | Under 11 | $282 |
| Dexamethasone Generic | 36 | 51 | 17 | $703 |
| Omeprazole Generic | 34 | 60 | 11 | $383 |
| Xtandi Enzalutamide | 32 | 32 | Under 11 | $452K |
| Acyclovir Generic | 32 | 50 | Under 11 | $256 |
| Ibrance Palbociclib | 31 | 31 | Under 11 | $488K |
| Letrozole Generic | 29 | 73 | Under 11 | $619 |
| Jakafi Ruxolitinib Phosphate | 29 | 29 | Under 11 | $519K |
| Verzenio Abemaciclib | 29 | 29 | Under 11 | $423K |
Brand drugs: 466 claims; generic drugs: 743 claims; opioid claims: 77.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Steven W Yates $99.99 ($99.99 in general payments such as food, travel and fees) from 1 company. The largest payer was Astellas Pharma US Inc with $99.99.
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc 4503.T | 1 | $99.99 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.